Pulmonary Fibrosis
The DOI matches its Crossref record, with a small difference in title or year; 37 of the 38 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Substantial challenges remain in our understanding of fibrotic lung diseases. Nowhere is this more true than in the elucidation and verification of the pathogenetic basis upon which they develop. Scientific progress, most recently in the field of experimental therapy, has relied closely on interpreting data derived from animal modeling. Such models are used to identify the cellular interactions and molecular pathways involved in lung tissue repair and fibrosis. Over the coming years, the significance of new discoveries will continue to be evaluated using the in vivo analysis of animal models substituting for patients with actual pulmonary fibrosis. The commonest strategy to induce experimental pulmonary fibrosis is by directly administering a profibrotic agent to either wild-type animals or those that bear a specific genetic modification. The creation of new models has been greatly enhanced by the availability of stem cell lines and methods for introducing genetic mutations into these cells. Despite an increasing choice of models, there are still good reasons to continue adapting and using one of its earliest examples, the bleomycin model, in post-genomic pulmonary fibrosis research. A brief review of the exacting requirements of such research will place the strengths of this particular model in perspective.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pulmonary fibrosis is also included in the host response to reverse the loss of essential metal after its sequestration by asbestos (Figure 3 and Figure 4) [64].”
From Asbestos and Iron (2023) · cites this paper as [64]
Citations
Cites
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Idiopathic Pulmonary Fibrosis: Clinical Relevance of Pathologic Classification
KATZENSTEIN, A.-L. A., & MYERS, J. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707039 · Cited by 1,261
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079
Sime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., & Gauldie, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119590 · Cited by 1,050
Self-citationLee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.809 · Cited by 940
Resolution of Lung Inflammation by CD44
Teder, P., Vandivier, R. W., Jiang, D., Liang, J., Cohn, L., Puré, E., Henson, P. M., & Noble, P. W. (2002) · Science · doi:10.1126/science.1069659 · Cited by 677
Selman, M., Ruiz, V., Cabrera, S., Segura, L., Ramírez, R., Barrios, R., & Pardo, A. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.3.l562 · Cited by 425
Kaminski, N., Allard, J. D., Pittet, J. F., Zuo, F., Griffiths, M. J. D., Morris, D., Huang, X., Sheppard, D., & Heller, R. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1778 · Cited by 417
Giri, S. N., Hyde, D. M., & Hollinger, M. A. (1993) · Thorax · doi:10.1136/thx.48.10.959 · Cited by 402
Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder
Selman, M., & Pardo, A. (2001) · Respiratory Research · doi:10.1186/rr175 · Cited by 379
Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice
Hattori, N., Degen, J. L., Sisson, T. H., Liu, H., Moore, B. B., Pandrangi, R. G., Simon, R. H., & Drew, A. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10531 · Cited by 265
Pulmonary Fibrosis and Chronic Lung Inflammation in ET-1 Transgenic Mice
Hocher, B., Schwarz, A., Fagan, K. A., Thöne-Reineke, C., El-Hag, K., Kusserow, H., Elitok, S., Bauer, C., Neumayer, H.-H., Rodman, D. M., et al. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.23.1.4030 · Cited by 219
Transient Transgene Expression of Decorin in the Lung Reduces the Fibrotic Response to Bleomycin
KOLB, M., MARGETTS, P. J., GALT, T., SIME, P. J., XING, Z., SCHMIDT, M., & GAULDIE, J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.3.2006084 · Cited by 189
Self-citationWang, Q., Wang, Y., Hyde, D. M., Gotwals, P. J., Koteliansky, V. E., Ryan, S. T., & Giri, S. N. (1999) · Thorax · doi:10.1136/thx.54.9.805 · Cited by 186
Gelatinase B Is Required for Alveolar Bronchiolization after Intratracheal Bleomycin
Betsuyaku, T., Fukuda, Y., Parks, W. C., Shipley, J. M., & Senior, R. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64563-4 · Cited by 185
Bleomycin-Induced Chronic Lung Damage Does Not Resemble Human Idiopathic Pulmonary Fibrosis
BORZONE, G., MORENO, R., URREA, R., MENESES, M., OYARZÚN, M., & LISBOA, C. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.2006132 · Cited by 171
Snider, G. L., Celli, B. R., Goldstein, R. H., O’Brien, J. J., & Lucey, E. C. (1978) · PubMed · doi:10.1164/arrd.1978.117.2.289 · Cited by 166
Saadeh, P. B., Mehrara, B. J., Steinbrech, D. S., Dudziak, M. E., Greenwald, J. A., Luchs, J. S., Spector, J. A., Ueno, H., Gittes, G. K., & Longaker, M. T. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.4.c628 · Cited by 164
EBIHARA, T., VENKATESAN, N., TANAKA, R., & LUDWIG, M. S. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.4.9912011 · Cited by 158
Bleomycin-induced interstitial pneumonia in dogs
Fleischman, R. W., Baker, J. R., Thompson, G. R., Schaeppi, U. H., Illievski, V. R., Cooney, D. A., & Davis, R. D. (1971) · Thorax · doi:10.1136/thx.26.6.675 · Cited by 142
Cytokines and Pulmonary Fibrosis
Zhang, K., & Phan, S. H. (1996) · Neurosignals · doi:10.1159/000109195 · Cited by 135
Hoyle, G. W., Li, J., Finkelstein, J. B., Eisenberg, T., Liu, J.-Y., Lasky, J. A., Athas, G., Morris, G. F., & Brody, A. R. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65432-6 · Cited by 132
Inflammatory Mechanisms Are a Minor Component of the Pathogenesis of Idiopathic Pulmonary Fibrosis
Gauldie, J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2202054 · Cited by 127
Self-citationA new direction in the pathogenesis of idiopathic pulmonary fibrosis?
Gauldie, J., Kolb, M., & Sime, P. J. (2001) · Respiratory Research · doi:10.1186/rr158 · Cited by 117
Self-citationEvolution of three patterns of intra‐alveolar fibrosis produced by bleomycin in rats
Usuki, J., & Fukuda, Y. (1995) · Pathology International · doi:10.1111/j.1440-1827.1995.tb03503.x · Cited by 101
Collagen accumulation is decreased in SPARC-null mice with bleomycin-induced pulmonary fibrosis
Strandjord, T. P., Madtes, D. K., Weiss, D. J., & Sage, E. H. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.277.3.l628 · Cited by 89
Bleomycin hydrolase and a genetic locus within the MHC affect risk for pulmonary fibrosis in mice
Haston, C. K., Wang, M., Dejournett, R. E., Zhou, X., Ni, D., Gu, X., King, T. M., Weil, M. M., Newman, R. A., Amos, C. I., et al. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.16.1855 · Cited by 86
Strieter, R. M. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2202055 · Cited by 78
Chronic Interstitial Pulmonary Fibrosis Produced in Hamsters by Endotracheal Bleomycin
Snider, G. L., Celli, B. R., Goldstein, R. H., et al. (2015) · American Review of Respiratory Disease · Cited by 75
Potential therapeutic implications of new insights into respiratory syncytial virus disease
Openshaw, P. (2002) · Respiratory Research · doi:10.1186/rr184 · Cited by 62
Resistance of TNF/LTα double deficient mice to bleomycin‐induced fibrosis
PIGUET, P. F., KAUFMAN, S., BARAZZONE, C., MULLER, M., RYFFEL, B., & EUGSTER, H. P. (1997) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.1997.d01-240.x · Cited by 45
Transforming growth factor ? and mouse development
Mummery, C. L. (2001) · Microscopy Research and Technique · doi:10.1002/1097-0029(20010215)52:4<374::aid-jemt1022>3.0.co;2-8 · Cited by 45
Frankel, S. K., Moats‐Staats, B. M., Cool, C. D., Wynes, M. W., Stiles, A. D., & Riches, D. W. H. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00420.2004 · Cited by 43
Harrison, J. H., & Lazo, J. S. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13257-6 · Cited by 37
Transforming growth factor ? and mouse development
Mummery, C. L. (2001) · Microscopy Research and Technique · doi:10.1002/1097-0029(20010215)52:4<411::aid-jemt1026>3.0.co;2-8 · Cited by 37
Lucey, E. C., Ngo, H. Q., Agarwal, A. R., Smith, B. D., Snider, G. L., & Goldstein, R. H. (1996) · PubMed · Cited by 26
McAnulty, R. J., Moores, S. R., Talbot, R. J. E., Bishop, J. E., Mays, P. K., & Laurent, G. J. (1991) · International Journal of Radiation Biology · doi:10.1080/09553009114550201 · Cited by 18
Self-citation
Research works printed but not linked: 5
- 1993, Monogr Pathol, 36, 78
- 2002, Respir Res, 3, 1
- 1978, Am Rev Respir Dis, 117, 289
- 1996, Lab Invest, 74, 12
- 1993, Thorax, 48, 956
Cited by
Moeller, A., Ask, K., Warburton, D., Gauldie, J., & Kolb, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.08.011 · Cited by 1,007
Self-citationStandardized Quantification of Pulmonary Fibrosis in Histological Samples
Hübner, R.-H., Gitter, W., Eddine El Mokhtari, N., Mathiak, M., Both, M., Bolte, H., Freitag-Wolf, S., & Bewig, B. (2008) · BioTechniques · doi:10.2144/000112729 · Cited by 817
“Animal models using bleomycin are an important tool for the analysis of pathogenetic processes in lung fibrosis and for the evaluation of new antifibrotic drugs (6,7), although processes involved in idiopathic pulmonary fibrosis (IPF) may not be identical (8).”
BackgroundMethodRegulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3
MacKinnon, A. C., Gibbons, M. A., Farnworth, S. L., Leffler, H., Nilsson, U. J., Delaine, T., Simpson, A. J., Forbes, S. J., Hirani, N., Gauldie, J., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201106-0965oc · Cited by 516
Self-citationFunctional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis
Königshoff, M., Balsara, N., Pfaff, E.-M., Kramer, M., Chrobak, I., Seeger, W., & Eickelberg, O. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002142 · Cited by 507
Inhibition of Wnt/β-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis
Henderson, W. R., Chi, E. Y., Ye, X., Nguyen, C., Tien, Y.-T., Zhou, B., Borok, Z., Knight, D. A., & Kahn, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001520107 · Cited by 462
Metadata
- Authors
- Chua, F., Gauldie, J., & Laurent, G. J.
- Affiliations
- The Royal Free Hospital (GB)
- ORCID
- Chua, Felix
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-07-01
- Volume
- 33
- Issue
- 1
- Pages
- 9-13
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- OpenAlex
- W2051772841
- Cited by
- 305
- References
- 36
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 10 · 2023: 24 · 2022: 18 · 2021: 7 · 2020: 12 · 2019: 7 · 2018: 13 · 2017: 17 · 2016: 7 · 2015: 12 · 2014: 19 · 2013: 19 · 2012: 12
- FWCI
- 4.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- pulmonary fibrosis, bleomycin-induced fibrosis, experimental fibrosis, genetic modification, stem cell lines, lung repair, fibrosis pathogenesis, postgenomics
- MeSH terms
- Animals, Antimetabolites, Antineoplastic, Bleomycin, Disease Models, Animal, Extracellular Matrix, Fibrosis, Humans, Lung, Lung Diseases, Models, Biological, Mutation, Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.